Axa S.A. Abb Vie Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Axa S.A. holds 846,325 shares of ABBV stock, worth $140 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

846,325

Previous 1,043,817 18.92%

Holding current value

$140 Million

Previous $179 Million 6.65%

% of portfolio

0.52%

Previous 0.54%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $32.4 Million - $39.4 Million	-197,492 Reduced 18.92%	846,325 $167 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $9.9 Million - $11.6 Million	-63,943 Reduced 5.77%	1,043,817 $179 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $6.5 Million - $7.41 Million	40,675 Added 3.81%	1,107,760 $202 Million
Q4 2023 Jul 16, 2024	SELL	$137.6 - $154.97 $5.6 Million - $6.3 Million	-40,675 Reduced 3.67%	1,067,085 $165 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $18.1 Million - $20.4 Million	-131,449 Reduced 10.97%	1,067,085 $165 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $39.8 Million - $46.1 Million	298,125 Added 33.11%	1,198,534 $179 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $26.2 Million - $32.6 Million	197,609 Added 28.12%	900,409 $121 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $32.6 Million - $37.5 Million	225,151 Added 47.14%	702,800 $112 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $3.81 Million - $4.57 Million	27,523 Added 6.11%	477,649 $77.2 Million
Q3 2022 Feb 14, 2023	SELL	$134.21 - $153.93 $13.3 Million - $15.2 Million	-98,834 Reduced 18.0%	450,126 $60.4 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $13.3 Million - $15.2 Million	-98,834 Reduced 18.0%	450,126 $60.4 Million
Q2 2022 Feb 14, 2023	SELL	$137.62 - $174.96 $25.1 Million - $31.9 Million	-182,575 Reduced 24.96%	548,960 $84.1 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $25.1 Million - $31.9 Million	-182,575 Reduced 24.96%	548,960 $84.1 Million
Q1 2022 Feb 14, 2023	BUY	$131.98 - $163.75 $37.1 Million - $46.1 Million	281,409 Added 62.52%	731,535 $119 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $39.2 Million - $48.6 Million	-296,812 Reduced 28.86%	731,535 $119 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $29.9 Million - $37.8 Million	-277,917 Reduced 21.28%	1,028,347 $139 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $32 Million - $36.3 Million	300,804 Added 29.92%	1,306,264 $141 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $20.1 Million - $22.4 Million	190,744 Added 23.41%	1,005,460 $113 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $4.52 Million - $4.98 Million	44,223 Added 5.74%	814,716 $88.2 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $3.48 Million - $4.7 Million	43,257 Added 5.95%	770,493 $82.6 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $5.91 Million - $6.94 Million	-68,842 Reduced 8.65%	727,236 $63.7 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $21.8 Million - $29.2 Million	297,331 Added 59.62%	796,078 $78.2 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $8.63 Million - $13.1 Million	133,800 Added 36.66%	498,747 $38 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $20.3 Million - $25.4 Million	-281,663 Reduced 43.56%	364,947 $32.3 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $3.05 Million - $3.67 Million	-48,497 Reduced 6.98%	646,610 $49 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $2.17 Million - $2.77 Million	-33,030 Reduced 4.54%	695,107 $50.5 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $4.37 Million - $5.15 Million	-56,675 Reduced 7.22%	728,137 $58.7 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $2.9 Million - $3.57 Million	-37,199 Reduced 4.53%	784,812 $72.4 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $192,223 - $213,692	2,162 Added 0.26%	822,011 $77.7 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $74.7 Million - $88.4 Million	-832,321 Reduced 50.38%	819,849 $76 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $36.8 Million - $49.2 Million	-399,615 Reduced 19.48%	1,652,170 $156 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $21 Million - $23 Million	234,158 Added 12.88%	2,051,785 $198 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $127 Million - $162 Million	1,817,627	1,817,627 $162 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account